- Home
- NVAX vs PARR Comparison
NVAX vs PARR Comparison
Compare NVAX & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- PARR
- Stock Information
- Founded
- NVAX 1987
- PARR 1984
- Country
- NVAX United States
- PARR United States
- Employees
- NVAX N/A
- PARR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- PARR Integrated oil Companies
- Sector
- NVAX Health Care
- PARR Energy
- Exchange
- NVAX Nasdaq
- PARR Nasdaq
- Market Cap
- NVAX 1.3B
- PARR 1.5B
- IPO Year
- NVAX 1995
- PARR N/A
- Fundamental
- Price
- NVAX $8.31
- PARR $35.63
- Analyst Decision
- NVAX Hold
- PARR Hold
- Analyst Count
- NVAX 5
- PARR 5
- Target Price
- NVAX $9.80
- PARR $33.40
- AVG Volume (30 Days)
- NVAX 4.6M
- PARR 1.0M
- Earning Date
- NVAX 11-11-2025
- PARR 11-04-2025
- Dividend Yield
- NVAX N/A
- PARR N/A
- EPS Growth
- NVAX N/A
- PARR N/A
- EPS
- NVAX 2.54
- PARR N/A
- Revenue
- NVAX $1,078,718,000.00
- PARR $7,614,628,000.00
- Revenue This Year
- NVAX $60.81
- PARR N/A
- Revenue Next Year
- NVAX N/A
- PARR N/A
- P/E Ratio
- NVAX $3.38
- PARR N/A
- Revenue Growth
- NVAX 9.22
- PARR N/A
- 52 Week Low
- NVAX $5.01
- PARR $11.86
- 52 Week High
- NVAX $11.55
- PARR $38.60
- Technical
- Relative Strength Index (RSI)
- NVAX 46.18
- PARR 52.02
- Support Level
- NVAX $8.02
- PARR $34.52
- Resistance Level
- NVAX $8.83
- PARR $36.34
- Average True Range (ATR)
- NVAX 0.47
- PARR 1.76
- MACD
- NVAX -0.09
- PARR -0.16
- Stochastic Oscillator
- NVAX 17.05
- PARR 53.66
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.